Pulmonx Corp (NASDAQ:LUNG), a company specializing in the development and commercialization of minimally invasive treatments for severe lung disease, has reported an insider sell according to a recent SEC filing.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles